A novel n-ras mutation in malignant melanoma is associated with excellent prognosis

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4916-4922

  Demunter, Anouk ^a   Ahmadian, Mohammad Reza ^c   Libbrecht, Louis ^a   Stas, Marguerite ^a   Baens, Mathijs ^b   Scheffzek, Klaus ^d   Degreef, Hugo ^a   De Wolf Peeters, Chris ^a   Van den Oord, Joost J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; RAS PROTEIN; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE MUTATION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

CODON; DNA, NEOPLASM; EXONS; FEMALE; GENES, RAS; GUANYLYL IMIDODIPHOSPHATE; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; POINT MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RAS PROTEINS; RETROSPECTIVE STUDIES;

EID: 0035874979     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation
2. Ras oncogenes in human cancer: A review
3. RAS genes
4. Yeast and mammalian RAS proteins have conserved biochemical properties
5. The product of RAS is a GTPase and the T24 oncogenic mutant is deficient in this activity
6. Biological and biochemical properties of human RASH genes mutated at codon 61
7. N-RAS mutations in T-cell acute lymphocytic leukemia: Analysis by direct sequencing detects a novel mutation
8. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
9. Amino-acid substitutions at codon 13 of the N-RAS oncogene in human acute myeloid leukemia
10. Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus
11. Structure and activation of the human N-RAS gene
12. Analysis of RAS oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with different phenotype
13. N-RAS mutations in human cutaneous melanoma from sun-exposed body sites
14. RAS mutations in human melanoma: A marker of malignant progression
15. Activation of N-RAS induced by ultraviolet irradiation in vitro
16. Sensitivity of melanoma cell lines to natural killer cells: A role for oncogene-modulated HLA class I expression?
17. A dot-blot screening procedure for mutated RAS oncogenes using synthetic oligonucleotides
18. A new American Joint Committee on Cancer staging system for cutaneous melanoma
19. Melanocytic tumors of the skin
20. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer
21. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization
22. Analysis of RAS oncogene mutations in human lymphoid malignancies
23. Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site
24. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21
25. Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides
26. Nonparametric estimation from incomplete observations
27. Asymptomatically efficient rank invariant procedures
28. Transforming genes of human hematopoietic tumors. Frequent detection of RAS-related oncogenes whose activation appears to be independent of tumor phenotype
29. Transforming genes in human leukemia cells
30. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes
31. Rapid detection of RAS oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer
32. RAS oncogene and p53 gene hotspot mutations in colorectal cancers
33. Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques
34. A high frequency of sequence alterations is due to formalin fixation of archival specimens
35. Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: A novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma
36. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-β
37. Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules
38. The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants
39. The Ras mutant D119N is both dominant negative and activated
40. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras
41. The GTPase superfamily: Conserved structure and molecular mechanism
42. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm